CPRX

Catalyst Pharmaceuticals
CPRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.87B
EV
$2.29B
Shares Outstanding
129.07M
Beta
0.72

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$34.29
P/E 2025E
15.20x
P/Revenue 2025E
5.12x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Catalyst Pharmaceuticals, Inc.

gainify
CPRX

Catalyst Pharmaceuticals, Inc.

CPRX

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampri...

Sector

Healthcare

Industry

Biotechnology

CEO

Daly, Richard John

Employees

181

IPO Date

2006-11-08

Headquarters

355 Alhambra Circle, Suite 801, Coral Gables, Florida, 33134, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.